Abenojar Tungsten plans London IPO amid Europe supply push

Spanish miner Abenojar Tungsten SA is considering a London IPO in 2026, working with Bank of Montreal, Deutsche Bank and Peel Hunt, with an announcement potentially due within weeks. The prospective listing is supported by Europe’s push to secure domestic tungsten supply, a critical input for renewable energy, aerospace and defense, amid China’s dominant global production position.

Analysis

The investable implication is not the underwriting fee pool for DB, BMO, or PEEL.L; a single sub-scale London listing will be immaterial to earnings. The more relevant signal is whether the issuer can secure long-dated European defense and industrial offtake before pricing. Such contracts would validate a regional tungsten premium and create a strategic-asset valuation framework, but they can also cap upside if buyers demand fixed-price supply in exchange for financing support.

Near-term, this is a watch catalyst rather than a commodity trade: tungsten has limited price transparency, no deep liquid equity proxy, and projects outside China frequently face permitting, processing, and commissioning risk. Over 6-18 months, sustained procurement localization would be marginally negative for tungsten-intensive tool makers such as KMT if input costs rise faster than they can pass through, while the earnings impact on defense primes LMT, RTX, and BAESY should remain negligible because tungsten is a small portion of system-level cost. The contrarian risk is that strategic-mineral enthusiasm assigns scarcity multiples to an asset before independently verified reserves, recovery rates, capex, and customer commitments establish economic viability.

Key Decisions for Investors

• No directional position in DB, BMO, or PEEL.L on this event; treat any IPO mandate as non-material to FY earnings. Reassess only if it signals a broader reopening of London mining issuance and mandate pipelines improve across multiple transactions.
• Add Abenojar Tungsten to the new-issue watchlist. Consider a post-listing long only after the prospectus discloses reserve life, processing recovery, all-in sustaining cost, funding gap, and binding offtake; require an implied EV/NPV discount of at least 30% to compensate for single-asset execution risk.
• Monitor KMT for a 1-3 month relative-short setup versus XLI if tungsten benchmarks or supplier contract prices rise while KMT does not raise guidance for price/cost recovery. Falsify the thesis if management demonstrates full pass-through or tungsten remains a de minimis share of input costs.
• Use European defense-procurement announcements as the key catalyst, not the IPO date. Binding multi-year domestic-content rules or strategic stockpile purchases would increase the probability of regional price support; absence of offtake at listing is a reason to avoid the equity rather than chase scarcity rhetoric.